Global Contraceptive Market, By Product (Drugs, Devices), By Nature (Conventional, Organic), By Gender (Female, Male),By End-User (Hospital Pharmacy, Online Channel, Public Channel, Clinics, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) Industry Trends and Forecast to 2030.
Global Contraceptive Market
The Global Contraceptive Market is expected to reach USD 26 billion by 2022, which will reach USD 35 billion in 2030, registering a CAGR of 5.08 % during the forecast period 2023-2030
About family planning and to help avoid unwanted pregnancy being some of the major key points increasing the market growth. The function of contraceptive pills is to avoid unwanted pregnancy, lower the risk of sexually transmitted diseases (STDs) and birth control rate resulting in rapidly increasing the market. The World Health Organization has launched an application describing the usage of contraceptives and measures and precautions for women with medical illness or health problems.
Market Drivers
Numerous treatments and research has been conducted to overcome the burden of unwanted pregnancy. Research is ongoing for non-hormonal pills which could expand the range of birth control options available to men. Several initiatives are being taken to create awareness of women’s contraceptives. A lot of marketing and branding has been carried out hence rising the growth market.
Market Restraints
The side-effects such as headaches, nausea, sore breasts and spotting are due to use of birth control pills. There is a lack of knowledge about contraceptive measures socially. Oral contraceptives can elevate heart diseases. IUDs can lead to risk of infection. Barrier contraceptives protect against sexually transmitted infection like HIV.
COVID-19 Impact on Global Bionic Market
The COVID-19 negatively impacted the industry. The use of contraceptives hamper’s the vaccine efficacy and side effects, such as blood clotting. Broadening access by telemarketing access and reaching out to deliver to places with lower healthcare providers.
Regional Analysis
Global Contraceptive Market is segmented into five main regions, namely, North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America has shown growth for the contraceptives market. The rising demand of contraceptives among women who are at risk of unplanned pregnancy especially in the U.S. and Canada are major key factors. Asia-Pacific dominates the market. The growth can be attributed to the rising number of government policies. There is demand for population control, and a decrease in the unintended pregnancy rate.
Market Segmentation
Global Contraceptive Market is segmented on the basis of By Product, By Nature, By End-User
Based on the By Product market is segmented into Drugs, Devices. Further market is segmented into By Nature market is segmented into Conventional, Organic. By End-User market is segmented into Hospital Pharmacy, Online Channel, Public Channel, Clinics, Others
Key Players
Various key players are listed in this report such as Bayer AG Pfizer Inc., Merck & Co Inc, Abbvie Inc, Ansell Inc, Mylan N.V, Allergan Plc,Church & Dwight Co Inc, Veru Inc, Pfizer Inc, Medisafe Distribution Inc.
Market Taxonomy
By Product
• Drugs
• Devices
By Nature
• Conventional
• Organic
By End-User
• Hospital Pharmacy
• Online
• Channel Public Channel
• Clinics
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Contraceptive Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
Global Contraceptive Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Contraceptive Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn.
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Contraceptive Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Contraceptive Market Share Analysis, By Product
5.3 Global Contraceptive Market Size and Forecast, By Product
5.3.1 Drugs
5.3.2 Devices
6 Global Contraceptive Market, By Nature
6.1 Y-o-Y Growth Comparison, By Nature
6.2 Global Contraceptive Market Share Analysis, By Nature
6.3 Global Contraceptive Market Size and Forecast, By Nature
6.3.1 Conventional
6.3.2 Organic
7 Global Contraceptive Market, By End Use
7.1 Y-o-Y Growth Comparison, By End Use
7.2 Global Contraceptive Market Share Analysis, By End Use
7.3 Global Contraceptive Market Size and Forecast, By End Use
7.3.1 Hospital Pharmacy
7.3.2 Online Channel
7.3.3 Public Channel
7.3.4 Clinics
8 Global Contraceptive Market, By Region
8.1 Global Contraceptive Market Share Analysis, By Region
8.2 Global Contraceptive Market Size and Forecast, By Region
8.3 Global Contraceptive Market Trends and Forecast, By Region
9 North America Contraceptive Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Contraceptive Market Share Analysis, By Product
9.3 North America Contraceptive Market Size and Forecast, By Nature
9.4 North America Contraceptive Market Size and Forecast, By End Use
9.5 North America Contraceptive Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1. Market Size and Forecast, By Product
9.5.1.2 Market Size and Forecast, By Nature
9.5.1.3. Market Size and Forecast, By End Use
9.5.2 Canada
9.5.2.1. Market Size and Forecast, By Product
9.5.2.2 Market Size and Forecast, By Nature
9.5.2.3. Market Size and Forecast, By End Use
9.5.3 Mexico
9.5.3.1. Market Size and Forecast, By Product
9.5.3.2 Market Size and Forecast, By Nature
9.5.3.3. Market Size and Forecast, By End Use
10 Europe Contraceptive Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Contraceptive Market Share Analysis, By Product
10.3 Europe Contraceptive Market Size and Forecast, By Nature
10.4 Europe Contraceptive Market Size and Forecast, By End Use
10.5 Europe Contraceptive Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1. Market Size and Forecast, By Product
10.5.1.2 Market Size and Forecast, By Nature
10.5.1.3. Market Size and Forecast, By End Use
10.5.2 France
10.5.2.1. Market Size and Forecast, By Product
10.5.2.2 Market Size and Forecast, By Nature
10.5.2.3. Market Size and Forecast, By End Use
10.5.3 UK
10.5.3.1. Market Size and Forecast, By Product
10.5.3.2 Market Size and Forecast, By Nature
10.5.3.3. Market Size and Forecast, By End Use
10.5.4. Russia
10.5.4.1. Market Size and Forecast, By Product
10.5.4.2 Market Size and Forecast, By Nature
10.5.4.3. Market Size and Forecast, By End Use
10.5.5. Italy
10.5.5.1. Market Size and Forecast, By Product
10.5.5.2 Market Size and Forecast, By Nature
10.5.5.3. Market Size and Forecast, By End Use
10.5.6. Spain
10.5.6.1. Market Size and Forecast, By Product
10.5.6.2 Market Size and Forecast, By Nature
10.5.6.3. Market Size and Forecast, By End Use
10.5.7. Rest of Europe
10.5.7.1. Market Size and Forecast, By Product
10.5.7.2 Market Size and Forecast, By Nature
10.5.7.3. Market Size and Forecast, By End Use
11 Asia Pacific Contraceptive Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Contraceptive Market Share Analysis, By Product
11.3 Asia Pacific Contraceptive Market Size and Forecast, By Nature
11.4 Asia Pacific Contraceptive Market Size and Forecast, By End Use
11.5 Asia Pacific Contraceptive Market Size and Forecast, By Country
11.5.1 China
11.5.1.1. Market Size and Forecast, By Product
11.5.1.2 Market Size and Forecast, By Nature
11.5.1.3. Market Size and Forecast, By End Use
11.5.2 Japan
11.5.2.1. Market Size and Forecast, By Product
11.5.2.2 Market Size and Forecast, By Nature
11.5.2.3. Market Size and Forecast, By End Use
11.5.3 India
11.5.3.1. Market Size and Forecast, By Product
11.5.3.2 Market Size and Forecast, By Nature
11.5.3.3. Market Size and Forecast, By End Use
11.5.4. South Korea
11.5.4.1. Market Size and Forecast, By Product
11.5.4.2 Market Size and Forecast, By Nature
11.5.4.3. Market Size and Forecast, By End Use
11.5.5. Australia
11.5.5.1. Market Size and Forecast, By Product
11.5.5.2 Market Size and Forecast, By Nature
11.5.5.3. Market Size and Forecast, By End Use
11.5.6. New Zealand
11.5.6.1. Market Size and Forecast, By Product
11.5.6.2 Market Size and Forecast, By Nature
11.5.6.3. Market Size and Forecast, By End Use
11.5.7. Singapore
11.5.7.1. Market Size and Forecast, By Product
11.5.7.2 Market Size and Forecast, By Nature
11.5.7.3. Market Size and Forecast, By End Use
11.5.8. Malaysia
11.5.8.1. Market Size and Forecast, By Product
11.5.8.2 Market Size and Forecast, By Nature
11.5.8.3. Market Size and Forecast, By End Use
11.5.9. Rest of Asia
11.5.9.1. Market Size and
